Neutralizing antibodies (NAbs) are the body’s defense mechanism against foreign pathogens (viruses). AAV is a type of virus used to deliver therapeutics – whether for gene replacement or gene editing. Individuals can have pre-existing NAbs to the AAV virus as a function of everyday life. Certain levels of NAbs can cause the body to attack the AAV virus instead of accepting it as a helpful therapeutic.
What are we doing about it?
CRD has partnered with the University of Massachusetts Medical School to provide Cure Rare Disease families the opportunity to gain knowledge about NAb levels in efforts to help themselves or their loved ones make the best decision for therapeutic options.